Latest CardioSignal News & Updates
See the latest news and media coverage for CardioSignal. We track all announcements, press releases, and industry mentions in real time, all in one place.
Smartphone-based atrial fibrillation detection device
cardiosignal.com- Headquarters
- Turku, Finland
- Founded year
- 2016
- Company type
- Private company
- Number of employees
- 30–50
Latest news about CardioSignal
Company announcements
-
CardioSignal wins Desafío DKV 2025 at Health4Good in Barcelona
Smartphone-based atrial fibrillation detection is selected as the winning digital screening solution. CardioSignal and DKV collaborate to integrate it into DKV's health ecosystem for insured customers.
-
CardioSignal rolls out its first MDR Class IIb app release
Updates feature sensor checks, refined vitals display, improved accessibility, quiet measurements, and revised documents. It launches CardioSignal Inside SDK for B2B partners.
-
CardioSignal attends the ESC Congress 2025 in Madrid
The company highlights its mission to provide reliable heart monitoring via smartphones and invites attendees to connect with their CEO and Medical Director at the event.
-
CardioSignal announces MDR Class IIb certification and new SDK model
CardioSignal achieved EU MDR Class IIb certification and will offer a new SDK partnership model for integrating atrial fibrillation detection into partner apps.
Media coverage
-
CardioSignal raises $10m to advance smartphone heart disease detection
Finnish health technology company CardioSignal has successfully secured $10 million in Series A funding, supporting its mission to advance...
-
FDA Approves Multimodal CardioTag Monitor
The new wearable technology can assess multiple cardiovascular metrics, including electrical impulses and blood flow, to alert patients and clinicians to worsening heart failure and...
-
5000 over 50-year-olds are offered a free app for trial that identifies a common heart rhythm disorder. Heart problems. In the illustration image, Meilahti's joint emergency services. IMAGE: Henri Kärkkäinen 8.6.202518:02 Rony Hopeakangas 5000 for 50-75-year-olds are offered..
5000 over 50-year-olds are offered a free app for trial that identifies a common heart rhythm disorder. Heart problems. In the illustration image, Meilahti's joint emergency services. IMAGE: Henri Kärkkäinen 8.6.202518:02 Rony Hopeakangas 5000 for 50-75-year-olds are offered...
-
Abstract 12517: CardioSignal Smartphone Application Detects Atrial Fibrillation in Heart Failure Population
Track CardioSignal and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
CardioSignal competitors & trending companies
Browse news for competitors to CardioSignal and other trending companies.
Cortrium
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove
Bluecore
BlueConic
Amperity
Wero
BLIK
EPI
Swish
Affirm
Brite Payments
TCS
Overview Energy
Adfin
Ineffable Intelligence
Mechanize
Hexatronic
Alimak Group
Lindab Group
NYAB
Noon Energy
Nordan AI
Mips
Vexlum
Asker Healthcare Group